Development and applications of oncolytic Maraba virus vaccines

Volume: Volume 7, Pages: 117 - 128
Published: Nov 1, 2018
Abstract
: Oncolytic activity of the MG1 strain of the Maraba vesiculovirus has proven efficacy in numerous preclinical cancer models, and relied not only on a direct cytotoxicity but also on the induction of both innate and adaptive antitumor immunity. To further expand tumor-specific T-cell effector and long-lasting memory compartments, we introduced the MG1 virus in a prime-boost cancer vaccine strategy. To this aim, a replication-incompetent...
Paper Details
Title
Development and applications of oncolytic Maraba virus vaccines
Published Date
Nov 1, 2018
Volume
Volume 7
Pages
117 - 128
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.